Invention Grant
- Patent Title: Use of interleukin 2 for treating Sjögren's syndrome
-
Application No.: US16965700Application Date: 2019-02-18
-
Publication No.: US11534479B2Publication Date: 2022-12-27
- Inventor: David Klatzmann , Roberta Lorenzon , Michèle Rosenzwajg , Patrice Cacoub , Arsene Mekinian
- Applicant: ILTOO PHARMA , ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS , SORBONNE UNIVERSITÉ
- Applicant Address: FR Paris; FR Paris; FR Paris
- Assignee: ILTOO PHARMA,ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS,SORBONNE UNIVERSITÉ
- Current Assignee: ILTOO PHARMA,ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS,SORBONNE UNIVERSITÉ
- Current Assignee Address: FR Paris; FR Paris; FR Paris
- Agency: McDermott Will & Emery LLP
- Priority: EP18305170 20180216
- International Application: PCT/EP2019/054002 WO 20190218
- International Announcement: WO2019/158764 WO 20190822
- Main IPC: A61K38/20
- IPC: A61K38/20 ; A61K47/68 ; A61K47/60 ; A61P37/00
Abstract:
The invention relates to the use of interleukin-2 in treating Sjögren's syndrome in a subject, wherein IL-2 is to be administered at a low dose of less than about 3.5 MIU/day.
Public/Granted literature
- US20210121532A1 USE OF INTERLEUKIN 2 FOR TREATING SJÖGREN'S SYNDROME Public/Granted day:2021-04-29
Information query
IPC分类:
